← Back to Search

Bowel Gas Detection Device for Laparoscopic Colectomy Procedures

N/A
Recruiting
Led By Alessio Pigazzi, MD,PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Documentation of a required elective right laparoscopic hemicolectomy with intracorporeal anastomosis
Be older than 18 years old
Must not have
Patients who are on peritoneal dialysis
Patients undergoing emergency laparotomy for perforated right colon or trauma
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during surgery(from start of laparoscopy to the end of surgical procedure)
Awards & highlights
No Placebo-Only Group

Summary

This trialwill evaluate a device that can detect bowel gas leakage during laparoscopic surgery, which can prevent severe complications and death caused by undetected perforation.

Who is the study for?
This trial is for adults over 18 who need elective laparoscopic right colectomy with intracorporeal anastomosis and can give informed consent. It's not for non-English speakers, emergency cases, peritoneal dialysis patients, those with abdominal infections or fistulas, or pregnant/breastfeeding individuals.
What is being tested?
The study tests a new device designed to detect bowel gas from perforations during laparoscopic surgery by sampling gases in the abdomen. The goal is to ensure it accurately identifies bowel gas without interrupting the procedure.
What are the potential side effects?
Since this trial involves testing a detection device rather than medication, traditional side effects are not expected. However, there may be minimal risks associated with attaching the device to surgical equipment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for a specific surgery on the right side of my colon.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently undergoing peritoneal dialysis.
Select...
I am having emergency surgery for a ruptured right colon or injury.
Select...
I do not speak English.
Select...
I am under 18 years old.
Select...
I have an abdominal infection, inflammation of the abdomen lining, or an abnormal connection in my intestine.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during surgery(from start of laparoscopy to the end of surgical procedure)
This trial's timeline: 3 weeks for screening, Varies for treatment, and during surgery(from start of laparoscopy to the end of surgical procedure) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hydrogen (H2) gas
Methane (CH4) gas
Secondary study objectives
Response time of the Perf-AlertTM device.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Cohort 2: Continuous monitoringExperimental Treatment1 Intervention
Cohort 2: Continuous monitoring: 10 subjects with continuous monitoring of bowel gases through the surgery. The level of H2 and CH4 gases will be noted at the 8 predetermined time points during the continuous monitoring as well.
Group II: Cohort 1: Predetermined points measurementExperimental Treatment1 Intervention
Cohort 1: Predetermined points measurement: 10 subjects with measurement of bowel gas at 8 predetermined time points during right laparoscopic colectomy as follow: 1. Initiation of surgery/laparoscopy start Insufflation 2. Abdominal exploration 3. Completion of colon mobilization 4. Colon transection 5. At Colotomy 6. At Enterotomy 7. Anastomosis completion 8. End of surgery- after re-insufflation before closure

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,084 Previous Clinical Trials
1,138,879 Total Patients Enrolled
Sentire Medical SystemsUNKNOWN
Alessio Pigazzi, MD,PhDPrincipal InvestigatorWeill Medical College of Cornell University
1 Previous Clinical Trials
12 Total Patients Enrolled

Media Library

Cohort 1: Predetermined points measurement Clinical Trial Eligibility Overview. Trial Name: NCT04964297 — N/A
Colon Cancer Research Study Groups: Cohort 1: Predetermined points measurement, Cohort 2: Continuous monitoring
Colon Cancer Clinical Trial 2023: Cohort 1: Predetermined points measurement Highlights & Side Effects. Trial Name: NCT04964297 — N/A
Cohort 1: Predetermined points measurement 2023 Treatment Timeline for Medical Study. Trial Name: NCT04964297 — N/A
~2 spots leftby Mar 2025